PROSPERI, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 27.344
EU - Europa 19.173
AS - Asia 12.022
SA - Sud America 1.795
AF - Africa 323
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 21
Totale 60.707
Nazione #
US - Stati Uniti d'America 25.989
SE - Svezia 6.625
SG - Singapore 3.926
IT - Italia 3.650
DE - Germania 2.682
CN - Cina 2.658
VN - Vietnam 1.968
HK - Hong Kong 1.420
BR - Brasile 1.372
RU - Federazione Russa 1.318
CA - Canada 1.156
DK - Danimarca 914
IE - Irlanda 891
GB - Regno Unito 666
UA - Ucraina 541
IN - India 496
FR - Francia 485
PL - Polonia 370
FI - Finlandia 275
AT - Austria 231
KR - Corea 229
ID - Indonesia 180
BD - Bangladesh 173
AR - Argentina 158
TR - Turchia 137
MX - Messico 130
IQ - Iraq 128
ES - Italia 124
PK - Pakistan 110
NL - Olanda 105
JP - Giappone 103
ZA - Sudafrica 98
SA - Arabia Saudita 73
PH - Filippine 64
CH - Svizzera 57
EC - Ecuador 56
UZ - Uzbekistan 52
CO - Colombia 51
VE - Venezuela 46
IR - Iran 40
BE - Belgio 39
CZ - Repubblica Ceca 38
KE - Kenya 37
MA - Marocco 36
CL - Cile 31
EG - Egitto 30
PY - Paraguay 30
MY - Malesia 25
AE - Emirati Arabi Uniti 24
IL - Israele 24
JO - Giordania 24
AZ - Azerbaigian 22
AU - Australia 21
ET - Etiopia 18
GR - Grecia 18
LT - Lituania 18
TN - Tunisia 18
EU - Europa 17
UY - Uruguay 17
PE - Perù 16
TW - Taiwan 16
BO - Bolivia 14
PT - Portogallo 14
RO - Romania 14
AL - Albania 13
BG - Bulgaria 13
CR - Costa Rica 13
DZ - Algeria 13
JM - Giamaica 13
TH - Thailandia 13
HU - Ungheria 12
KG - Kirghizistan 11
MU - Mauritius 11
NP - Nepal 11
DO - Repubblica Dominicana 10
LB - Libano 10
NO - Norvegia 10
OM - Oman 10
KZ - Kazakistan 9
LV - Lettonia 9
NG - Nigeria 9
MO - Macao, regione amministrativa speciale della Cina 8
PA - Panama 8
QA - Qatar 8
AO - Angola 7
BY - Bielorussia 7
PS - Palestinian Territory 7
RS - Serbia 7
SC - Seychelles 7
CI - Costa d'Avorio 6
CY - Cipro 6
GA - Gabon 6
NZ - Nuova Zelanda 6
SN - Senegal 6
TT - Trinidad e Tobago 6
GE - Georgia 5
HN - Honduras 5
LU - Lussemburgo 5
MD - Moldavia 5
MM - Myanmar 5
Totale 60.618
Città #
Ann Arbor 7.834
Stockholm 5.615
Singapore 2.256
Frankfurt am Main 2.225
Ashburn 1.831
Woodbridge 1.588
Fairfield 1.435
Hong Kong 1.373
Milan 1.295
San Jose 1.196
Chandler 1.082
Houston 1.031
Dublin 858
Wilmington 840
Toronto 803
Jacksonville 553
Seattle 552
New York 522
Dearborn 514
Cambridge 483
Ho Chi Minh City 478
Santa Clara 468
Los Angeles 404
Hanoi 401
Beijing 362
Dallas 353
Chicago 320
Hefei 293
Princeton 290
Kraków 264
The Dalles 220
Council Bluffs 207
Nanjing 196
Vienna 195
Shanghai 191
Dong Ket 185
Seoul 166
Buffalo 149
Lauterbourg 148
Lawrence 144
Altamura 136
São Paulo 132
Jakarta 122
Guangzhou 114
Boardman 112
Munich 107
Helsinki 101
San Diego 90
Moscow 89
Fremont 86
Lachine 85
London 84
Rome 84
Montréal 77
Warsaw 76
Tokyo 75
Brooklyn 74
Da Nang 74
Orem 74
Haiphong 71
Montreal 64
Chennai 60
Baghdad 57
Nanchang 57
Nuremberg 55
Turku 55
Kent 54
Ottawa 53
Changsha 51
Florence 49
Shenyang 48
Denver 46
Pavia 46
Tashkent 46
Phoenix 45
Johannesburg 44
Tianjin 44
Rio de Janeiro 42
Turin 42
Salt Lake City 41
Monza 40
Mumbai 39
Belo Horizonte 37
Pune 37
Hyderabad 35
Mexico City 35
Poplar 35
Atlanta 34
Columbus 34
Desio 34
Hebei 34
Palermo 33
Biên Hòa 31
Zurich 31
Brussels 30
Nairobi 30
Boston 29
Jinan 29
Amsterdam 28
Kunming 28
Totale 42.845
Nome #
Biomimetic responsive antigen-delivery vehicles for therapeutic and preventive vaccines against hereditary triple-negative breast cancer 1.969
Harnessing Mirror-Image Peptides: Nanoparticle Vectors for Nucleic Acid Delivery 1.941
Nanoparticle-Mediated Laser Ablation: An Integrated Phantom Experimental-Computational Framework for Selective Cancer Therapy 1.910
MnO Nanoparticles Embedded in Functional Polymers as T1 Contrast Agents for Magnetic Resonance Imaging 665
H-Ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies 649
Inositol 1,4,5-trisphosphate 3-kinase B promotes Ca2+mobilization and the inflammatory activity of dendritic cells 647
Engineered Ferritin Nanoparticles for the Bioluminescence Tracking of Nanodrug Delivery in Cancer 637
Thirty years of cancer nanomedicine: Success, frustration, and hope 626
Killing cancer cells by targeting the tumor microenvironment: study of TRAIL journey in a CAFs model 619
Modeling the interaction of amphiphilic polymer nanoparticles with biomembranes to Guide rational design of drug delivery systems 601
Uniform lipopolysaccharide (LPS)-loaded magnetic nanoparticles for the investigation of LPS-TLR4 signaling 598
The emerging role of nanotechnology in skincare 595
Multifunctional Magnetic Gold Nanomaterials for Cancer 573
Functionalization of colloidal nanoparticles with a discrete number of ligands based on a “HALO-bioclick” reaction 566
H-Ferritin Enriches the Curcumin Uptake and Improves the Therapeutic Efficacy in Triple Negative Breast Cancer Cells 556
Negatively charged silver nanoparticles with potent antibacterial activity and reduced toxicity for pharmaceutical preparations 554
Are nanotechnological approaches the future of treating inflammatory diseases? 553
Does conjugation strategy matter? Cetuximab-conjugated gold nanocages for targeting triple-negative breast cancer cells 550
Targeted delivery of nanoparticles 542
99mTc-radiolabeled silica nanocarriers for targeted detection and treatment of HER2-positive breast cancer 541
Monitoring the fate of orally administered plga nanoformulation for local delivery of therapeutic drugs 531
Development of99mtc-radiolabeled nanosilica for targeted detection of HER2-positive breast cancer 526
Nanoparticle-Mediated Suicide Gene Therapy for Triple Negative Breast Cancer Treatment 519
Colloidal polymer-coated Zn-doped iron oxide nanoparticles with high relaxivity and specific absorption rate for efficient magnetic resonance imaging and magnetic hyperthermia 517
Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with Navitoclax 516
Investigation of antitumor activities of trastuzumab delivered by PLGA nanoparticles 489
Bioengineered Approaches for Site Orientation of Peptide-Based Ligands of Nanomaterials 483
Loading Imatinib inside targeted nanoparticles to prevent Bronchiolitis Obliterans Syndrome 483
Cetuximab-conjugates nanoparticles for the treatment of triple negative breast cancer 460
Relaxometric studies of Gd-Chelate conjugated on the surface of differently shaped gold nanoparticles 454
Theranostic Nanocages for Imaging and Photothermal Therapy of Prostate Cancer Cells by Active Targeting of Neuropeptide-Y Receptor 449
“Blind” targeting in action: From phage display to breast cancer cell targeting with peptide-gold nanoconjugates 448
Dynamic molecular exchange and conformational transitions of alpha-synuclein at the nano-bio interface 447
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 445
Evaluation of tfr-1 expression in feline mammary cancer and in vitro antitumor efficacy study of doxorubicin-loaded h-ferritin nanocages 442
Specific immunosuppressive role of nanodrugs targeting calcineurin in innate myeloid cells 439
A fast and straightforward procedure for vault nanoparticle purification and the characterization of its endocytic uptake 435
Metronomic nanocaged doxorubicin prevents chemoresistance and cardiotoxicity in breast cancer 435
Tumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies 425
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study 425
Half-Chain Cetuximab Nanoconjugates Allow Multitarget Therapy of Triple Negative Breast Cancer 420
Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells 415
H-Ferritin-nanocaged olaparib: A promising choice for both BRCA-mutated and sporadic triple negative breast cancer 415
Impact of the strategy adopted for drug loading in nonporous silica nanoparticles on the drug release and cytotoxic activity 409
Anti-madcam-1-conjugated nanocarriers delivering quantum dots enable specific imaging of inflammatory bowel disease 406
Advanced Cell Culture Models Illuminate the Interplay between Mammary Tumor Cells and Activated Fibroblasts 404
Evaluation of gold nanoparticles biocompatibility: a multiparametric study on cultured endothelial cells and macrophages 404
Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model 404
Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity 389
Olaparib nanoformulation in H-Ferritin for the triple negative breast cancer treatment 388
Half-Chain trastuzumab nanoconjugates enhance antitumor activity in HER2+ breast cancer 383
Saporin Toxin Delivered by Engineered Colloidal Nanoparticles Is Strongly Effective against Cancer Cells 378
Conformational properties of intrinsically disordered proteins bound to the surface of silica nanoparticles 378
Nanoformulation of antiretroviral drugs enhances their penetration across the blood brain barrier in mice 372
Recent advances in magnetic fluid hyperthermia for cancer therapy 371
Preface frontiers in cancer immunotherapy: Understanding the role of gut microbiota 370
Development of an Effective Tumor-Targeted Contrast Agent for Magnetic Resonance Imaging Based on Mn/H-Ferritin Nanocomplexes 368
Surfactant protein D (SP-D) as a biomarker of SARS-CoV-2 infection 367
Peptide-nanoparticle ligation mediated by cutinase fusion for the development of cancer cell-targeted nanoconjugates 360
Loss of exosomes in progranulin-associated frontotemporal dementia 358
Delivering colloidal nanoparticles to mammalian cells: a nano-bio interface perspective 357
Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents 355
Suicide gene therapy: A new frontier for cancer fighting 353
Assessing the in vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands 351
Conjugation of gold nanoparticles with multidentate surfactants for enhanced stability and biological properties 349
Nano-targeting of Mucosal Addressin Cell Adhesion Molecule-1 identifies bowel inflammation foci in murine model 344
Orientation-controlled conjugation of haloalkane dehalogenase fused homing peptides to multifunctional nanoparticles for the specific recognition of cancer cells 340
O6-alkylguanine-DNA transferase (SNAP) as capture module for site-specific covalent bioconjugation of targeting protein on nanoparticles 339
Dependence of nanoparticle-cell recognition efficiency from surface orientation of scFv targeting ligands 335
Curcumin Formulations and Trials: What’s New in Neurological Diseases 334
Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages 333
Single-domain protein A-engineered magnetic nanoparticles: toward a universal strategy to site-specific labeling of antibodies for targeted detection of tumor cells 329
Combined mass quantitation and phenotyping of intact extracellular vesicles by a microarray platform 328
Nanoparticle-mediated delivery of suicide genes in cancer therapy 322
Stem Cell-Mediated Exon Skipping of the Dystrophin Gene by the Bystander Effect 315
Meet our editor-in-chief 314
Development of U11-functionalized gold nanoparticles for selective targeting of urokinase plasminogen activator receptor-positive breast cancer cells 312
Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction 312
MAdCAM-1 nanotargeting uncovers bowel inflammation foci in experimental model of colitis 312
Co-processed materials testing as excipients to produce Orally Disintegrating Tablets (ODT) using binder jet 3D-printing technology 306
Site-Specific Conjugation of ScFvs Antibodies to Nanoparticles by Bioorthogonal Strain-Promoted Alkyne-Nitrone Cycloaddition 305
HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches 304
Microfluidic nanoparticle synthesis for oral solid dosage forms: A step toward clinical transition processes 302
Click Chemistry Immobilization of Antibodies on Polymer Coated Gold Nanoparticles 302
Detection of nanostructures in solutions of Zincum metallicum and the vehicle lactose 301
Protein-Assisted One-Pot Synthesis and Biofunctionalization of Spherical Gold Nanoparticles for Selective Targeting of Cancer Cells 297
Antiproliferative effect of ASC-J9 delivered by PLGA nanoparticles against estrogen-dependent breast cancer cells 293
Gold nanocages for imaging and therapy of prostate cancer cells 287
Immobilization of carboxypeptidase from Sulfolobus solfataricus on magnetic nanoparticles improves enzyme stability and functionality in organic media 286
Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases 286
TGF-β Signaling Loop in Pancreatic Ductal Adenocarcinoma Activates Fibroblasts and Increases Tumor Cell Aggressiveness 285
The synthesis of allolactose from amygdalin 285
Light scattered by model phantom bacteria reveals molecular interactions at their surface 284
Intracellular Drug Release from Curcumin-Loaded PLGA Nanoparticles Induces G2/M Block in Breast Cancer Cells 280
Towards ideal magnetofluorescent nanoparticles for bimodal detection of breast-cancer cells 278
Heteronanoparticles by Self-Assembly of Ecdysteroid and Doxorubicin Conjugates to Overcome Cancer Resistance 278
Direct quantification of cytosolic delivery of drug nanocarriers using FlAsH-EDT2 278
Dual-Targeting Strategy to Repurpose Cetuximab with HFn Nanoconjugates for Immunotherapy of Triple-Negative Breast Cancer 277
Gold nanoparticles decorated by clustered multivalent cone-glycocalixarenes actively improve the targeting efficiency toward cancer cells 277
Impact of semi-solid formulations on skin penetration of iron oxide nanoparticles 277
Totale 45.421
Categoria #
all - tutte 158.406
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 158.406


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.347 0 0 0 0 0 0 0 0 0 0 499 848
2021/20225.546 605 587 601 526 334 352 451 410 317 355 390 618
2022/20235.893 745 1.452 720 619 524 793 127 210 372 102 138 91
2023/20242.895 123 86 161 131 350 624 655 96 172 76 82 339
2024/20257.258 371 601 677 364 633 308 484 298 745 1.072 647 1.058
2025/202622.545 2.024 1.015 1.220 1.811 2.040 973 2.703 880 1.535 7.176 1.168 0
Totale 61.954